According to Ravi Wankhedkar, member, Indian Medical Association (IMA), rural and tribal areas are facing a grim situation and have increased the incidence of infection due to malnutrition leading to …
clinical
-
-
NEW DELHI : Serum Institute of India’s phase 2 and 3 bridging study of 1,600 participants for the covid-19 vaccine Covovax has started at one of the trial sites in …
- Sports
I-League 2021: Chennai City FC’s clinical performance see them beat NEROCA FC 2-1, jump to top half of points table – Sports News , Firstpost
Strikes from Vineeth Kumar (sixth minute) and Demir Avdic (68th) were enough to hand Chennai City the win despite Subash Singh reducing the deficit in the 79th minute. Despite a …
- Sports
India vs England: Clinical visitors revel in Chepauk cauldron to take 1-0 lead in series – Firstcricket News, Firstpost
When India last lost a Test at home, Steven Smith was the Australian captain, Joe Root was yet to lead England in a Test, and Virat Kohli had 43 hundreds …
-
New data showing that two COVID-19 vaccines are far less effective in South Africa than in other places they were tested have heightened fears that the coronavirus is quickly finding …
-
A clinical display of accurate bowling and powerful hitting helped Qalandars to trounce Pune Devils by nine wickets, in the fourth match of the Abu Dhabi T10 at the Abu …
-
A brace from Jorge Ortiz and Naveen Kumar’s brilliance in goal helped FC Goa script a 3-0 win over Jamshedpur FC in the Indian Super League (ISL) at the Fatorda …
-
The Washington Post is reporting that a recent Trump appointee to the National Oceanic and Atmospheric Administration (NOAA) released unauthorized climate papers bearing the imprint of the Executive Office of …
- News
Covaxin use in clinical trial mode, clarifies health minister after DCGI approval; India’s COVID-19 cases rise to 1.03 cr – Health News , Firstpost
Drug firm Zydus Cadila also received the go-ahead to conduct phase-3 trails for its vaccine candidate ZyCoV-D — the country’s first DNA vaccine candidate against the novel coronavirus infection. As …
-
Hours after Drugs Controller General of India (DCGI) approved restricted use in an emergency situation to Bharat Biotech`s COVID-19 vaccine, Indian Council of Medical Research (ICMR) on Sunday said data …
- News
Coronavirus live updates | Over 100 experts from friendly nations trained for clinical trials of Indian vaccine
The interim findings from the phase-1 placebo-controlled randomised double-blind trial on the safety and immunogenicity of three different formulations of BBV152 reported the results of the trial on 375 participants, …
- News
Over 100 Experts from Friendly Nations Trained for Clinical Trials of Indian Covid-19 Vaccine: Official
Over 100 experts from friendly neighbouring nations have so far been trained to strengthen capacities in their countries for facilitating phase-3 clinical trials of Indian COVID-19 vaccine, a senior official …
- News
There’s Been No Compromise In Clinical Testing Of Covid-19 Vaccines: Clinical Scientist Gagandeep Kang
Seeking to allay people’s apprehension over the safety and efficacy of Covid-19 vaccines, noted clinical scientist Gagandeep Kang said that though vaccines for coronavirus are being developed in a short …
-
Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers. The National Institute of …
- News
Six COVID vaccine candidates in different clinical trial stages in India: Union Health Secretary
Union Health Secretary Rajesh Bhushan on Tuesday said that there are six COVID-19 vaccine candidates in different clinical trial stages being developed by various manufacturers in India. Besides this, three …
- News
CSIR to decide on human clinical trials of Molnupiravir –– a drug that blocks SARS-CoV-2 in 24 hours
Written by Anuradha Mascarenhas | Pune | Updated: December 7, 2020 12:06:50 pm According to the researchers, Molnupiravir is the first oral anti-viral drug to quickly block SARS-CoV 2. (Representational …
-
By: PTI | Pune | Updated: December 6, 2020 6:47:07 pm Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct …
-
The Phase-III clinical trial of Covid-19 vaccine (Covaxin) being developed by Bharat Biotech would begin at the privately-run Vydehi multi-specialty hospital here from Wednesday, an official said on Tuesday. “The …
-
Phase 2/3 clinical trials for Sputnik V, the first registered Covid-19 vaccine from Russia commenced in India on Tuesday. Russian Direct Investment Fund (RDIF) and Dr Reddy`s Laboratories today said …
-
Phase 2/3 clinical trials for Sputnik V, the first registered Covid-19 vaccine from Russia, commenced in India on Tuesday. Dr Reddy’s Laboratories Ltd and Russian Direct Investment Fund (RDIF) announced …